What is translational research?

Why does the list of chromosomal abnormalities that are consider high risk change or evolve over time?
What are the International Myeloma Working Group's consensus imaging guidelines for myeloma?
Is there a higher prevalence of amyloidosis in African Americans?
Why is it important for a patient to know the cytogenetic abnormalities of their myeloma?
What is hyperdiploid and hypodiploid myeloma?
Why may real world data not always reflect what was learned in a clinical trial?
Why may real world data not always reflect what was learned in a clinical trial?
Would drugs used to treat Alzheimer's be useful to treat myeloma or amyloidosis?